title: 2-Aminoethoxydiphenyl borate directly inhibits store-operated calcium entry channels in human platelets.
abstract: In this study, we examined 2-aminoethoxydiphenyl borate (2APB) as an inhibitor of Ca(2+) influx in human platelets. 2APB was found to inhibit thrombin-mediated intracellular Ca(2+) mobilization rapidly in platelets incubated in the absence of extracellular Ca(2+). This result supports an intracellular action of 2APB on inositol 1,4,5-trisphosphate (IP(3))-receptor Ca(2+) channels. 2APB was without effect on the ability of thapsigargin to mobilize intracellular Ca(2+). This result suggests that the efflux of Ca(2+) from the endoplasmic reticulum mediated by thapsigargin is not via IP(3) Ca(2+) channels. However, 2APB was able to prevent the entry of Ca(2+) and Sr(2+) through thapsigargin-activated, store-operated Ca(2+) channels (SOCC). This result supports a direct inhibitory effect of 2APB on SOCC. 2APB was also able to block the entry of Sr(2+), Ba(2+), and Mn(2+) entry into unstimulated platelets, which suggests that 2APB was inhibiting the Ca(2+) influx channels directly. The capacity of 2APB to prevent Ca(2+) influx and Sr(2+) influx was rapid because it occurred immediately upon addition to the platelets. The inhibition of Ca(2+) and Sr(2+) influx by 2APB was similar to that seen with the cell-impermeable nonselective Ca(2+)-channel blocker La(3+) or the Ca(2+) chelator EGTA. Diphenylboronic anhydride and 2,2-diphenyltetrahydrofuran, two compounds that are structurally similar to 2APB, also inhibited Ca(2+) influx. It was concluded that 2APB was a rapid and effective direct inhibitor of SOCC in human platelets; as such, it cannot be used to support the involvement of IP(3) receptors in the activation of SOCC.
authors.affiliation: Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, Virginia 23501-1980, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Dobrydneva
authors.forename: P
authors.initials: P
authors.lastname: Blackmore
mesh_terms: D001464:Barium / Q000378:metabolism; D001692:Biological Transport; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D001896:Boron Compounds / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism*; D015220:Calcium Channels / Q000378:metabolism*; D006801:Humans; D015759:Ionomycin / Q000494:pharmacology; D007476:Ionophores / Q000494:pharmacology; D008345:Manganese / Q000378:metabolism; D013324:Strontium / Q000378:metabolism; D019284:Thapsigargin / Q000378:metabolism; D013917:Thrombin / Q000378:metabolism; D013995:Time
chemical_list: D001896:Boron Compounds; D015220:Calcium Channels; D007476:Ionophores; D001464:Barium; D008345:Manganese; D015759:Ionomycin; D019284:Thapsigargin; C109986:2-aminoethoxydiphenyl borate; D013917:Thrombin; D002118:Calcium; D013324:Strontium